curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years

by palligoelme@gmail.com | Sep 22, 2026 | Clinical Trials

​ Conditions: Persistent Allergic Rhinitis Interventions: Drug: DEP114; Drug: Desloratadine Sponsors: EMS Not yet recruiting Conditions: Persistent Allergic Rhinitis Interventions: Drug: DEP114; Drug: Desloratadine Sponsors: EMS Not yet...

Biopsy-site-marker in Breast Cancer

by palligoelme@gmail.com | Sep 22, 2026 | Clinical Trials

​ Conditions: Breast Cancer Interventions: Device: Biopsy-Site Marker Placement. Sponsors: University of Oklahoma Recruiting Conditions: Breast Cancer Interventions: Device: Biopsy-Site Marker Placement. Sponsors: University of Oklahoma...

Effect of Aronia Supplementation on the LPS-CD14-TLR2/4 Axis in Football Players

by palligoelme@gmail.com | Sep 21, 2026 | Clinical Trials

​ Conditions: Exercise Training Interventions: Dietary Supplement: Aronia melanocarpa Extract; Dietary Supplement: Dietary Supplement: Placebo Sponsors: Hanna Dziewiecka; Poznan University of Medical Sciences Not yet recruiting Conditions: Exercise Training...

Professional Oral Care and Staff Education in Critically Ill Patients

by palligoelme@gmail.com | Sep 21, 2026 | Clinical Trials

​ Conditions: Critically Ill; Oral Health Care; Critical Illness; Oral Care Performance Interventions: Behavioral: Professional Oral Care; Behavioral: Standard Oral Care; Behavioral: ICU Staff Oral Care Education Sponsors: Semmelweis University Completed Conditions:...

The Effect of a Postbiotic on Oral Health in Healthy Adults

by palligoelme@gmail.com | Sep 21, 2026 | Clinical Trials

​ Conditions: Healthy Interventions: Dietary Supplement: Postbiotic; Dietary Supplement: Placebo Sponsors: The Archer-Daniels-Midland Company; Nutrasource Pharmaceutical and Nutraceutical Services, Inc. Not yet recruiting Conditions: Healthy Interventions: Dietary...

Resmetirom in Patients With MASH and HFpEF

by palligoelme@gmail.com | Sep 21, 2026 | Clinical Trials

​ Conditions: MASH – Metabolic Dysfunction-Associated Steatohepatitis; Heart Failure With Preserved Ejection Fraction (HFPEF) Interventions: Drug: Resmetirom; Drug: Placebo Sponsors: Madrigal Pharmaceuticals, Inc. Not yet recruiting Conditions: MASH –...
« Older Entries
Next Entries »

Recent Posts

  • GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
  • Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma
  • ABVN Phase 2 – Vagal Maneuvers
  • A Test of Acceptance-based Bibliotherapy for Hoarding Disorder
  • Semaglutide for the Treatment of Cannabis Use Disorder

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®